Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Treasury Shares: 2020-2025

Historic Treasury Shares for Tango Therapeutics (TNGX) over the last 3 years, with Sep 2025 value amounting to $1.3 million.

  • Tango Therapeutics' Treasury Shares rose 6.55% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 6.55%. This contributed to the annual value of $1.2 million for FY2024, which is 59.64% up from last year.
  • As of Q3 2025, Tango Therapeutics' Treasury Shares stood at $1.3 million, which was down 9.60% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Tango Therapeutics' Treasury Shares ranged from a high of $1.5 million in Q1 2025 and a low of $633,626 during Q1 2023.
  • Moreover, its 3-year median value for Treasury Shares was $1.2 million (2024), whereas its average is $1.1 million.
  • Data for Tango Therapeutics' Treasury Shares shows a peak YoY surged of 97.98% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Tango Therapeutics' Treasury Shares stood at $757,514 in 2023, then spiked by 59.64% to $1.2 million in 2024, then increased by 6.55% to $1.3 million in 2025.
  • Its Treasury Shares stands at $1.3 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.5 million for Q1 2025.